Effects of Pantoprazole on Systemic and Gastric Pro- and Anti-inflammatory Cytokines in Critically Ill Patients
| Author | Hamed Tabeefar | en |
| Author | Mohammad Taghi Beigmohammadi | en |
| Author | Mohammad Reza Javadi | en |
| Author | Mohammad Abdollahi | en |
| Author | Ata Mahmoodpoor | en |
| Author | Arezoo Ahmadi | en |
| Author | Hooshyar Honarmand | en |
| Author | Atabak Najafi | en |
| Author | Mojtaba Mojtahedzadeh | en |
| Issued Date | 2012-10-31 | en |
| Abstract | Stress-related mucosal damage (SRMD) is a significant cause of morbidity and mortality in critically ill patients due to the gastrointestinal blood loss. Prophylaxis of SRMD with proton pump inhibitors or histamine-2 blockers has gained widespread use in intensive care units. Both demonstrated to be effective in reducing clinically significant bleedings, while PPIs has shown to exert some anti inflammatory effects including the inhibition of producing pro-inflammatory cytokines. As cytokines have role in developing SRMD, the aim of this study was to evaluate the effect of PPIs on the inhibition of cytokine release following the critical illness. | en |
| DOI | https://doi.org/10.22037/ijpr.2012.1196 | en |
| Keyword | Pantoprazole | en |
| Keyword | Cytokines | en |
| Keyword | Stress-related mucosal damage prophylaxis | en |
| Keyword | Critically ill patients | en |
| Publisher | Brieflands | en |
| Title | Effects of Pantoprazole on Systemic and Gastric Pro- and Anti-inflammatory Cytokines in Critically Ill Patients | en |
| Type | Original Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- ijpr-11-1051.pdf
- Size:
- 621.58 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF